Extending antiretroviral therapy to resource-poor settings
2004; Lippincott Williams & Wilkins; Volume: 18; Issue: Supplement 3 Linguagem: Inglês
10.1097/00002030-200406003-00009
ISSN1473-5571
Autores Tópico(s)HIV Research and Treatment
ResumoThe emergence of drug resistance in human immunodeficiency virus type 1 (HIV-1) may limit the clinical benefits of antiretroviral therapy. There is no objective evidence that the risk of drug resistance is greater in resource-limited settings than in the developed world. Treatment programmes will be most successful at preventing the spread of drug resistance if they provide healthcare infrastructures to maximize the effectiveness of antiretroviral therapy through the use of potent and convenient combination regimens that achieve durable suppression of HIV-1 replication.
Referência(s)